Artiva Biotherapeutics Operating Income

Artiva Biotherapeutics (ARTV) currently reports a operating income of $-97M as of June 2026. That compares with $-82M in the prior-year period — down 18.8% year over year. Use the charts on this page to explore Artiva Biotherapeutics's operating income history and peer comparisons.

Artiva Biotherapeutics's operating income decreased from $-82M to $-97M — a 18.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Artiva Biotherapeutics reported $-97M in operating income as of June 2026. That compares with $-82M in the prior-year period — down 18.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-97M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Artiva Biotherapeutics, and consider following ARTV for alerts when major investors trade the stock.